Zusammenfassung
Proliferation vaskulärer Strukturen, spindelförmige Zellen und extravasale Erythrozyten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Kotz KW, Krigel RL (1993) “Epidemic Kaposi’s Sarcoma”. In: Meiderhuber (ed) Current Therapy in Oncology
Serraino D, Franceschi S, Tirelli U et al. (1992) The epidemiobgy of acquired immune defldiency and associated tumours in Europe. Ann Onc 3: 595–603
Beral V, Peterman TA, Berkelman RL et al. (1990) Kaposi’s Sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335: 123–128
Bunikowski R, Estemiann J, Koch M (1992) AIDS in Germany: Clinical manifestations of AIDS. Medizinische Klinik 87: 1–7
Armes J (1989) A review of Kaposi’s Sarcoma. Adv Ca Res 53: 73–87
Huang YO, Li JJ, Resh MG et al. (1992) HPV-16-related DNA sequences in Kaposi’s Sarcoma. Lancet 339: 515–518
Chachoua A, Krigel R, Lafleur et al. (1989) Prognostic factors and staging classification of patients with epidemic Kaposi’s Sarcoma. J Clin Oncol 7: 774–780
Krown SE, Metroka C, Wernz JC et al. (1989) Kaposi’s Sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7: 1201-1207
Epstein JB, Lozada-Nur F, McLeod A et al. (1989) Oral Kaposi’s Sarcoma in acquired immunodeficiency syndrome: Review of management and report of the efficacy of intralesional vinblastine. Cancer 64: 2424-2430
Berson AM, Quivey JM, Harris JW et al. (1990) Radiation therapy for AIDS-Related Kaposi’s Sarcoma. Int J Rad Onc Biol Phys 19: 569–575
Gill PS, Loureiro C, Bernstein-Singer M et al. (1989) Clinical effect of glucocorticoids on Kaposi’s Sarcoma related to the acquired immunodeficiency syndrome ( AIDS ). Ann Int Med 110: 937-940
Hirsch M, D’Aquilla RT (1993) Therapy for human immunodeficiency virus infection. N Engl J Med 328: 1686–1695
Ensoli B, Barillari G, Salahuddin SZ et al. (1990) Tat protein of HIV stimulates growth of cells derived from Kaposi’s Sarcoma lesions of AIDS patients. Nature 345: 84 – 86
Palca J (1992) Kaposi’s Sarcoma gives on key fronts. Science 255: 1352–1364
Nakamura S, Sakurada S, Salahuddin SZ et al. (1992) Inhibition of development of Kaposi’s Sarcoma-related lesions by a bacterial cell wall complex. Science 285: 1437–1440
Wallstein K, Zugmaier G, Calitano J et al. (1991) Tumor growth dependent on Kaposi’s Sarcoma-derived Fibroblast Growth Factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716–720
Evana LM, Itri IM, Campion M et al. (1991) Interferon-alpha in the treatment of acquired immunodeficiency syndrome-related Kaposi’s Sarcoma. J Immunother 10: 39–50
Volberding PA, Abrams DI, Conant M et al. (1985) Vinblastine therapy for Kaposi’s Sarcoma in the acquired immunodeficiency syndrome. Ann Int Med 103: 335–338
Mintzer DM, Real FM, Jovino L et al. (1985) Treatment of Kaposi’s Sarcoma and thrombocytopenis with vincristine in patients with acquired immunodeficiency syndrome. Ann Int Med 102: 200–202
Laubenstein LF, Krigel RL, Odajnyk CM et al. (1984) Treatment of epidemic Kaposi’s Sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2: 1115–1130
Lassoued K, Clauval J, Katlama C et al. (1990) Treatment of the acquired immune deficiency syndrome-related Kaposi’s Sarcoma with bleomycin as a single agent. Cancer 66: 1869–1872
Gill PS, Rarick M, McCutchan A et al. (1991) Systemic treatment of AIDS-related Kaposi’s Sarcoma: Results of a randomized trial. Am J Med 90: 427–433
Kaplan L, Abrams D, Volberding P (1986) Treatment of Kaposi’s Sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 70: 1121–1122
Gill P, Rarick M, Bernstein-Singer M et al. (1990) Treatment of advanced Kaposi’s Sarcoma using a combination of bleomycin and vincristine. J Clin Oncol 13: 315–319
Rarick MU, Gill PS, Montgomery T et al. (1990) Treatment of epidemic Kaposi’s Sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1: 147–149
Presant CA, Scolaro M, Kennedy P et al. (1992) Liposomal daunorubicin as tumor-targeted chemotherapy: Initial clinical results in Kaposi’s Sarcoma and solid tumors. Proc Am Soc Clin Oncol 11: 46
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kotz, K., Krigel, R.L. (1993). Kaposi-Sarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_36
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive